ghk cu tolerance desensitization long term use Does GHK-Cu Really Work? 40 Years of Research Reviewed The Effect of the Human
Description
This peptide is derived from a protective protein found in the stomach

Phase Phase 5 High escalation Weeks Weeks 1720 Dose 12.5 mg once weekly Notes Transitional

I am not over eating like normal and I am feeling great

Amycretin (NNC0487-0111) Novo Nordisk is currently conducting phase 1 clinical trials (NCT05369390, NCT06049329 and NCT06064006) to evaluate amycretin (NNC0487-0111), an oral and/or SC formulation combining GLP-1 RA and amylin peptides [126]
[DOI] [PMC free article] [PubMed] [Google Scholar] Zhang Q
